Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
University of Washington Department of Laboratory Medicine, |
RCV000210111 | SCV000266207 | uncertain significance | Lynch syndrome | 2015-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000217860 | SCV000276264 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-05-17 | criteria provided, single submitter | clinical testing | The p.R901S variant (also known as c.2701C>A), located in coding exon 4 of the MSH6 gene, results from a C to A substitution at nucleotide position 2701. The arginine at codon 901 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000693978 | SCV000822402 | benign | Hereditary nonpolyposis colorectal neoplasms | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002469072 | SCV002765570 | uncertain significance | not provided | 2022-12-19 | criteria provided, single submitter | clinical testing | Observed in an individual with colorectal cancer (Shirts et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 17531815, 21120944, 26845104) |
All of Us Research Program, |
RCV000210111 | SCV004841939 | uncertain significance | Lynch syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing | This missense variant replaces arginine with serine at codon 901 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with early onset colorectal cancer (PMID: 26845104). This variant has been identified in 3/282050 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV004567494 | SCV005054819 | uncertain significance | Endometrial carcinoma | 2024-03-26 | criteria provided, single submitter | clinical testing |